Blaschko-linear syringocystadenoma papilliferum: A peculiar presentation

Giant linear syringocystadenoma papilliferum on scalp.

minutes 00 seconds), clotting time (4 minutes 10 seconds), active partial thrombin time (27.4 seconds; normal range-24-32 seconds), prothrombin time, blood peripheral smear examination, liver function tests and renal function tests were all within normal limits. Urine and stool examination did not reveal erythrocytes or any abnormalities. Upper gastro-intestinal endoscopy and ultrasound of the ...

Syringocystadenoma papilliferum Authors: Doctor

Giant naevoid syringocystadenoma papilliferum.

Sir, Syringocystadenoma papilliferum (SCAP) is a rare tumour first described in 1893 (1). To date, 400 cases have been reported worldwide. SCAP usually appears at birth or in early childhood, most frequently on the face or scalp. In approximately 25% of cases it is observed on other locations such as the trunk or the extremities. In 40% of cases, SCAP evolves contiguous to a pre-existing naevus...

Somatic V600E BRAF mutation in linear and sporadic syringocystadenoma papilliferum

Jonathan L. Levinsohn(1),(2),(3), Jeffrey L. Sugarman(4), Kaya Bilguvar(1),(5), Jennifer M. McNiff(2),(3), The Yale Center for Mendelian Genomics, and Keith A. Choate(1),(2),(3) (1)Department of Genetics, Yale University, New Haven, Connecticut (2)Department of Pathology, Yale University, New Haven, Connecticut (3)Department of Dermatology, Yale University, New Haven, Connecticut (4)Departments...

Giant condyloma acuminata with syringocystadenoma papilliferum.

350 six months. The same lesion had gradually increased to attain the present size. Family and personal history were not contributory. Dermatological examination revealed two skin lesions on the medial aspect of the right thigh [Figure 1]. The larger one was 6 × 7 cm in size and smaller one was 1 × 3 cm in size. Both were firm in consistency, non-tender, mobile on the underlying structure, caul...